← Leaderboards
Rita Sattler
Johns Hopkins University
$4,305,341
Attributed
$7,752,391
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,752,391 · 7
By mechanism
R01$6,038,025 · 2
R21$1,704,366 · 4
R13$10,000 · 1
Top collaborators
- Jeffrey D Rothstein6 shared
- Matt Huentelman4 shared
- Kendall R Van Keuren-Jensen4 shared
- Ignazio Stefano Piras1 shared
- Daniela C Zarnescu1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Alex L Kolodkin$19,223,792
- Sarah Hatch Berth$1,063,555
- Zachary Bryant Nicholas$100,512
- Philip C Wong$27,601,264
- Shanthini Sockanathan$12,143,558
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsMolecularC9orf72TissuesAutopsyNovel TherapeuticsFunctional DisorderGenesPathologyPathologicMutationMotor NeuronsPhenotypeCellsValidationAstrocytesFutureCell LineNerve DegenerationCell TypeLaboratoriesDrug DiscoveryInduced Pluripotent Stem Cell
Grant awards (20)
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$788,244
R01 · FY2025 · NS · contact PI
Cross validation of gene expression changes in C9orf72 FTD using Drosophila and human model systems$432,802
R21 · FY2025 · NS
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$64,322
R01 · FY2025 · NS · contact PI
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$811,977
R01 · FY2024 · NS · contact PI
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$64,322
R01 · FY2024 · NS · contact PI
The role of an aberrant synaptome in microglia-associated synaptic pruning in C9orf72-FTD$27,240
R01 · FY2024 · NS · contact PI
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$805,554
R01 · FY2023 · NS · contact PI
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$831,382
R01 · FY2022 · NS · contact PI
Transcriptomic assessment of pathology in PD with dementia and dementia with Lewy Bodies using iPSC neurons and brain tissue of the same individuals$423,274
R21 · FY2022 · NS · contact PI
Mechanisms of A-I RNA editing-mediated nuclear export of TDP-43$345,566
R21 · FY2022 · NS · contact PI
Astrocyte regulation of cortical neurodegeneration in C9orf72 FTD/ALS$87,087
R21 · FY2022 · NS · contact PI
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$836,154
R01 · FY2021 · NS · contact PI
Astrocyte regulation of cortical neurodegeneration in C9orf72 FTD/ALS$415,637
R21 · FY2021 · NS · contact PI
2019 Amyotrophic Lateral Sclerosis (ALS) & Related Motor Neuron Diseases GRC/GRS$10,000
R13 · FY2019 · NS · contact PI
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models$354,375
R01 · FY2017 · NS
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models$354,375
R01 · FY2016 · NS
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models$354,375
R01 · FY2015 · NS
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models$40,500
R01 · FY2015 · NS
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models$350,830
R01 · FY2014 · NS
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models$354,375
R01 · FY2013 · NS